A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Celgene Corporation
With
Pfizer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 18 years or older
Diagnosis of colorectal cancer or adenocarcinoma of the appendix
A tumor mass that can be measured
Resolution of all toxic effects of any radiotherapy or surgical procedures to NCI CTC grade less than or equal to 1
Willingness and ability to comply with scheduled visits, treatment plan, and laboratory tests, and other study procedures
You may not be if
Women that are pregnant or lactating
Prior treatment with Irinotecan
Partial or complete bowel obstruction, known chronic malabsorption, or total colectomy or other major abdominal surgery that might result in substantial alteration in transit or absorption of oral medication
Administration of the last dose of any previous adjuvant therapy for colorectal cancer within 6 months previous to randomization
Current enrollment in another clinical trial
Administration of any prior systemic anticancer therapy for metastatic colorectal cancer
Clareo Health | A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer
